Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.34 |
| ▸ | IDO1 | P14902 | 3/20 | 0.33 |
| ▸ | TDO2 | P48775 | 2/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
| ▸ | ADCY5 | O95622 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16718992 | 0.90 | TDO2 (0.33) | IDO1TDO2RORC | |
| SCHEMBL20169605 | 0.85 | CYP11B2 (0.33) | IDO1ALOX5APFEN1 | |
| SCHEMBL20170406 | 0.85 | CYP11B2 (0.33) | IDO1ALOX5APFEN1 | |
| SCHEMBL16718995 | 0.78 | OGA (0.38) | IDO1TDO2RORC | |
| SCHEMBL16720946 | 0.77 | CYP11B2 (0.32) | IDO1 | |
| SCHEMBL20170466 | 0.72 | IDO1 (0.38) | IDO1TDO2 | |
| SCHEMBL16719064 | 0.70 | TDO2 (0.40) | IDO1TDO2 | |
| SCHEMBL18307188 | 0.69 | HRH3 (0.40) | HRH3HTR6 | |
| SCHEMBL20170514 | 0.67 | KCNH2 (0.32) | HRH3 | |
| SCHEMBL20170495 | 0.67 | CYP11B2 (0.33) | HRH3IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3068391-B1 | ARYL LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG | MERCK SHARP & DOHME (US) | 2018-05-23 | — | — | EP | disclosed |